← Leaderboards
Justin Gregory
Vanderbilt University
$1,326,425
Attributed
$1,326,425
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $658.7K · FY2013–24$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,326,425 · 4
By mechanism
R01$658,746 · 2
K23$557,805 · 1
F32$109,874 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- David H Wasserman$26,902,229
- Alan D Cherrington$25,582,234
- Owen P McGuinness$19,104,126
- Richard M O'Brien$22,760,592
- Darleen A Sandoval$8,966,707
Others in their field
Top investigators on “Hyperglycemia”
- Rose A Gubitosi-Klug · Case Western Reserve University$72,785,524
- Jeffrey P Krischer · University Of South Florida$36,581,753
- Boyd E Metzger · Northwestern University$36,326,756
- Anastassios G Pittas · Tufts Medical Center$31,052,547
- George L King · Joslin Diabetes Center$27,911,701
- John M Lachin · George Washington University$21,318,885
Research focus
HyperglycemiaInsulinInsulin-Dependent Diabetes MellitusPeripheralPhysiologicalLiverFutureCanis FamiliarisTissuesPancreasMetabolicHepaticPhysiologyPortal Vein StructureAnalogResearch PersonnelMentorsExposure ToMediatingInsulin ResistanceInsulin SensitivityCardiometabolismBlood CirculationEndothelium
Grant awards (7)
Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes$340,747
R01 · FY2024 · DK · contact PI
Optimizing Stage 2 T1DM Management: Assessing the Impact of GLP-1Ra on Metabolic Outcomes in Patients Receiving Teplizumab$317,999
R01 · FY2024 · DK · contact PI
Determination of Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Recent-Onset Type 1 Diabetes$185,435
K23 · FY2022 · DK · contact PI
Determination of Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Recent-Onset Type 1 Diabetes$185,435
K23 · FY2021 · DK · contact PI
Determination of Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Recent-Onset Type 1 Diabetes$186,935
K23 · FY2020 · DK · contact PI
Relevance of the Route of Insulin Delivery to the Develpment of Hypoglycemia$52,140
F32 · FY2014 · DK · contact PI
Relevance of the Route of Insulin Delivery to the Develpment of Hypoglycemia$57,734
F32 · FY2013 · DK · contact PI